Press Releases IQ-AI Limited

Equities

Delayed London S.E. Other stock markets 10:00:42 2024-05-13 am EDT			5-day change	1st Jan Change
1.565 ^GBX	-5.15%		-2.19%	-66.70%

May. 10	IQ-AI subsidiary gets rare paediatric disease designation FDA	AN
May. 10	IQ-AI's Imaging Biometrics Obtains Rare Pediatric Disease Designation for Lead Drug Candidate	MT

IQ-AI advances glioblastoma clinical trial, eyes phase two in 2025	Feb. 26	AQ
IQ-AI Limited shares latest progress from Phase I glioblastoma clinical trial	23-07-19	AQ
IQ AI : Conversion of Loan Notes - Correction	20-02-05	PU

No results for this search